SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about postal ballot notice

30 Nov 2022 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company had conducted the process of Postal Ballot through remote e-voting for seeking the consent of the shareholders by means of passing Ordinary Resolutions as for Appointment of Bhushan Akshikar (DIN: 09112346) as a Director; and Appointment of Bhushan Akshikar (DIN: 09112346) as Manaaina Director. In Compliance with the provisions of Regulations 44(3) of the LODR, Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management & Administration) Rules 2014 as amended and the applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India the Company had provided voting facility to all its members to enable them to cast their vote on all matters listed in the Notice convening the Postal Ballot through electronic means during the period commencing from Monday 31st October2022 (09.00 am) and ended on Tuesday, 29th November 2022 (5.00 pm). In this Connection, it enclosed the following: Details regarding the voting results pursuant to Regulation 44(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015; and Scrutinizer Report. 

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×